$177.00
PT‑141 (or Bremelanotide) is a synthetic peptide derived from Melanotan II. It binds to receptors in the brain that govern arousal, motivation, and influencing libido. Although it’s approved for use in women, both research studies and anecdotal evidence indicate that PT‑141 may also benefit men with erectile dysfunction—especially those who do not respond adequately to PDE‑5 inhibitors (i.e. sildenafil or tadalafil).
Our discrete Telehealth Service Plan includes:
PT‑141 works by activating melanocortin receptors—specifically MC3R and MC4R—in the hypothalamus, the brain region that governs sexual arousal and motivation. This activation boosts dopamine signaling, enhancing the neurotransmitter’s role in sexual drive and reward pathways. Unlike conventional erectile‑dysfunction medications, PT‑141 does not depend on the nitric‑oxide cascade, so it remains effective for people who do not respond to PDE‑5 inhibitors. Because its primary action is central rather than vascular, PT‑141 may influence both psychological arousal and physical readiness.
Clinical observations show that its effects can be felt within 30 to 60 minutes after dosing, making it suitable for on‑demand use. By targeting the neural pathways of desire, PT‑141 may increase libido itself, not merely the mechanics of sexual performance.
Reviews
There are no reviews yet.